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Introduction
Trichomonas vaginalis is the causative agent of one of the most common sexually transmitted diseases, trichomoniasis. 1 Approximately 5 million cases of trichomonal vaginitis are reported annually in North America. Worldwide, over 170 million cases of trichomoniasis are reported each year. Infection is acquired primarily through transmission of trophozoites by direct sexual contact, although neonatal infection has also been reported. 2 Trichomoniasis is associated with adverse pregnancy outcomes, enhanced predisposition to HIV infection and risk of cervical neoplasia. 3, 4 A unique feature of the T. vaginalis life cycle is the reversible morphological transformation from the trophozoite stage to the amoeboid or pseudocyst stage. The parasite multiplies in the vagina or prostate of infected hosts in the trophozoite form. When it attaches to the surface of vagina epithelial cells, the trophozoite transforms to an amoeboid stage and induces acute inflammation of the vagina, resulting in a yellowish-green foul-smelling discharge in some females. Transformation to the amoeboid stage is crucial for establishment and maintenance of T. vaginalis infection in the vagina. Several proteins that mediate adherence, such as surface proteins (AP120, AP65, AP51, AP33, AP23), 5, 6 cysteine proteinases, 7 glyceraldehyde 3-phosphate dehydrogenase, 8 and lipophosphoglycan, 9 have been identified. Increasing evidence demonstrates that T. vaginalis can survive in the form of a pseudocyst under unfavorable environmental conditions, such as nutrient deprivation, the presence of drugs or dramatic changes in temperature. 10 In this form, the parasite becomes nonmotile and the flagellae are internalized, but a true cyst wall is not formed. Recent studies indicate that the pseudocyst stage is reversible and represents a defense mechanism against conditions detrimental to trichomonad survival. 11, 12 This pseudocystic stage is probably responsible for transmission of trichomoniasis via non-sexual contact. At present, how transformation between the trophozoite, amoeboid and pseudocyst stages is controlled and regulated in T. vaginalis remains largely unknown.
The modulation of protein phosphorylation through the antagonistic effects of protein kinases and protein phosphatases is a major regulatory mechanism for most cellular processes. Protein kinases are one of the major classes of enzymes involved in signal transduction and signaling networks. Many growth factors, cytokines and antigens initiate signaling events through protein phosphorylation, leading to cellular responses such as gene expression, changes in cell shape and migration, entry into the cell cycle, and proliferation. Protein phosphorylation is a major mechanism by which external stimuli are transformed into intracellular signals to which cells respond. It has been estimated that 30e50% of intracellular proteins are phosphorylated at some point in their lifetime. 13 The T. vaginalis kinome comprises more than 880 eukaryotic protein kinases and 40 atypical protein kinases, making it one of the largest kinomes identified to date. 14 Large-scale gene expression analysis using expressed sequence tags showed that 451 kinase genes (50% of the kinome) are expressed. At present, it is not known if any of these kinases participate in the transformation of trophozoites into amoeboids or pseudocysts. An alternative approach to explore the function of these kinases in the transformation process is to investigate the phosphoproteome of T. vaginalis and to use the resulting data set as a basis for deducing the kinaseesubstrate interaction network. In the present study, we elucidated the expression profile of phosphoproteins in the trophozoite, pseudocyst and amoeboid stages of T. vaginalis using a reverse-phase LC/MS/MS system.
Methods

Cell culture
T. vaginalis isolate ATCC30236 (JH 31A#4) was maintained in YIS medium, pH 5.8, containing 10% heat-inactivated fetal calf serum at 37 C. 15 The number of viable cells was determined based on hemocytometer counts using Trypan blue exclusion. Trophozoites grown to the late logarithmic phase with more than 90% viable cells were harvested for further study. The pseudocyst stage was induced by incubating trophozoites in late logarithmic phase on ice for 4 hours. The amoeboid stage was induced by growing trophozoites in late logarithmic phase in fibronectin-coated T-75 flasks for 3 hours at 37 C.
Preparation of cell extracts, digestion of protein mixtures and enrichment of phosphopeptides T. vaginalis cells from trophozoites, pseudocysts and amoeboids were harvested by centrifugation at 3000 rpm for 15 minutes and were washed there times in normal saline. Cell pellets were resuspended in lysis buffer (8 M urea, 4% CHAPS) containing protease inhibitors (Roche Diagnostics, Basel, Switzerland) at a cell density of approximately 1.2 Â 10 8 cells/ mL. Cells were disrupted by ultrasonication (XL2000, Misonix Inc., Farmingdale, NY, USA) in an ice bath for eight cycles, each consisting of 10 seconds of sonication followed by a 10-second break. After centrifugation at 4 C and 13,000 rpm for 15 minutes, impurities in the supernatant were removed using a 2D cleanup kit (GE Healthcare, Taipei, Taiwan). For tryptic digestion, the protein mixtures were diluted in 50 mM ammonium bicarbonate (Sigma, St. Louis, MO, USA) and digested with sequencing-grade trypsin (1:50 w/w; Promega, Madison, WI, USA) at 56 C for 1 hour. The digested lysate was reduced with 25 mM NH 4 HCO 3 (Sigma) containing 10 mM dithiothreitol (DTT; Sigma) at 37 C for 30 minutes and then alkylated with 55 mM iodoacetamide (Sigma) at room temperature for 30 minutes. After further reduction with 10 mM DTT at room temperature for 30 minutes, the protein mixtures were digested with sequencing-grade trypsin (20 mg/mL; Promega) at 37 C overnight. The T. vaginalis phosphopeptides were enriched using a PHOS-TRAP phosphopeptide enrichment kit (Perkin Elmer, Waltham, MA, USA) according to the manufacturer's protocol.
LC/MS/MS
The enriched phosphopeptides from trophozoites, pseudocysts and amoeboids were separated using a gradient system on a 10-cm analytical C18 column (inner diameter, 75 mm) with a 15-mm tip (New Objective, Woburn, MA, USA) as previously described. 16 Analytes in the eluent were detected with an online LTQ-Orbitrap linear ion-trap mass spectrometer (Thermo Fisher, San Jose, CA, USA).
Sequence database search and data analysis
The resulting MS/MS spectra for the phosphoproteome were used to search reference amino acid sequences downloaded from the TrichDB database (release 1.2; http://eupathdb.org/eupathdb/) using the X! Tandem (CYCLONE release) 17 and MASCOT search engines (Matrix Science, London, UK; version 2.2.07). For protein identification, mass tolerance of 2 Da was permitted for intact peptide masses and 1 Da for fragment ions, with allowance for two missed cleavages in the trypsin digest, oxidized methionine (þ15.99 Da) and phosphorylation (S, T, Y, þ79.98 Da) as potential variable modifications and carbamidomethyl cysteines (C, þ57.05 Da) as fixed modifications. The experimental data were searched and merged with different search engine results.
Results
T. vaginalis phosphoproteome
To determine the profile of phosphoproteins expressed in cells of the three different T. vaginalis stages, total protein lysates were extracted from trophozoites, pseudocysts and amoeboids and subjected to in-solution tryptic digestion followed by TiO 2 enrichment and LTQ-Orbitrap MS analysis. The resulting MS and MS/MS spectra were searched against the TrichDB database (release 1.2) using the MASCOT and X! Tandem search engines. The experimental design is summarized as a flowchart in Fig. 1 . To increase the accuracy of phosphopeptide identification, only phosphopeptides that were identified by both search engines were considered. A total of 93 unique peptides representing 82 proteins were retained for subsequent analysis. A summary of the phosphopeptides identified is presented in Table 1 . There were 84 peptides with one phosphorylated site, eight peptides with two phosphorylated sites, and one peptide with three phosphorylated sites. Fig. 2 shows the distribution of 82 phosphoproteins among the different stages of T. vaginalis. A total of 52, 59 and 41 phosphoproteins were expressed in the trophozoite, pseudocyst and amoeboid stages, respectively. Only 21 common enriched proteins were shared by the three stages; 32 proteins were stage specific, and 29 proteins were expressed in two different stages. The distribution of the phosphorylation sites identified is summarized in Fig. 3 . The percentage of phosphorylated serine, threonine and tyrosine sites was 71.8%, 21.4% and 6.8%, respectively.
Gene ontology analysis
To obtain an overview of the functional distribution of phosphoproteins identified in the present study, gene ontology (GO) annotation terms were used to classify the phosphorylated proteins into three categories: biological process, cellular component, or molecular function. The 82 phosphorylated proteins identified were searched against the NCBI non-redundant (nr) protein database with a cutoff e-value of 10
À3 . The GO annotation of these proteins was inferred from the results of a sequence homology search using Blast2GO software. 18 A total of 41 of the phosphorylated proteins were annotated with at least one GO term. Some 28, 34 and 19 proteins were classified into the biological process, molecular function and cellular component categories, respectively. The distribution of level 2 GO terms in the three categories is summarized in Fig. 4 .
Discussion
The 14-3-3 family is a group of highly conserved 30-kDa proteins expressed in a wide range of organisms and tissues. This protein family is involved in many biological processes, including regulation of the cell cycle, cell signaling, intracellular trafficking, transcription and cytoskeletal structure. 19 These regulatory networks are usually involved in phosphorylation of interacting proteins that show a distinct preference for a particular 14-3-3 isoform. A number of 14-3-3 sequences have been isolated from protists and characterized. 20 For example, 14-3-3 proteins have been identified in apicomplexan protozoans such as Plasmodium falciparum 21 and Toxoplasma gondii. 22 Expression of 14-3-3 proteins in P. falciparum begins during the ring stage, increases in young trophozoites, and declines thereafter. In T. gondii, 14-3-3 protein expression was found in feline enteroepithelial gametocyte stages, sporozoites, tachyzoites and bradyzoites. In addition, screening of cDNA libraries from Entamoeba histolytica and Trypanosoma brucei led to the identification of several 14-3-3 proteinlike sequences.
22 Although 14-3-3 proteins have been identified in some parasitic organisms, the biological roles of these proteins in protists remain unclear and should be investigated further. Many researchers have speculated that 14-3-3 proteins play a role in signal transduction related to cellular processes such as proliferation, migration and morphological changes during the parasite life cycle. In the present study, we demonstrated that a 14-3-3 protein (TVAG_256840) can be phosphorylated in different stages of T. vaginalis, a result that has not been reported previously. These results suggest that 14-3-3 phosphorylation may be a crucial post-translational modification that allows T. vaginalis to adapt to diverse environments.
We previously established a proteome reference map for T. vaginalis by 2D electrophoresis combined with MALDI- TOF-MS. 23 Among the proteins identified, proteins related to carbohydrate metabolism represented the most abundant category, accounting for 24.7% of all proteins. This result implies that carbohydrate metabolism may be one of the most important physiological processes in T. vaginalis. Several glycolytic enzymes have been described in previous studies 24 ; however, regulation of carbohydrate metabolism has not been elucidated in T. vaginalis or in other protists.
In this study, we demonstrated that glucokinase (TVAG_260790) and glycogen phosphorylase (TVAG_348330) are phosphorylated in different stages of T. vaginalis, suggesting that regulation of glucose homeostasis is a crucial physiological process for T. vaginalis under different conditions. A previous study showed that glucokinase (GK) purified from rat liver can be phosphorylated on a serine residue by protein kinase A (PKA). 25 A later study confirmed that GK phosphorylation by PKA led to a concomitant decrease in GK activity. 26 Conversely, GK activation results in an increase in glucose 6-P concentration, which has a synergistic effect with glucose in promoting dephosphorylation and thus inactivation of glycogen phosphorylase (GP). 27 Moreover, defects in both GK activation and GP dephosphorylation may contribute to dysregulation of glucose concentrations, resulting in type 2 diabetes in humans. On the basis of previous observations, we postulate that T. vaginalis may have a similar regulatory system to modulate glucose concentrations. Phosphoproteins identified in all three stages of T. vaginalis, such as 14-3-3 protein and several glycolytic enzymes, have also been identified in other higher organisms, suggesting that these proteins are highly conserved and their phosphorylation signals are essential in different stages.
We identified several peptides that are phosphorylated only in the trophozoite stage (Table 1) . Eukaryotic peptide chain release factors (eRF) (TVAG_003250) composed of eRF1 and eRF3 are associated with translation termination in eukaryotes.
28 eRF1 recognizes all three stop codons and induces hydrolysis of the peptidyletRNA bond. eRF3 carries four GTP-binding motifs associated with eRF1 to form a complex and stimulates eRF1 release activity in a GTPdependent manner. 29 However, eRF3 may have nontranslational functions, such as cell cycle regulation and cytoskeleton organization. Further functional characterization demonstrated that eRF3 depletion decreases the global translation rate and reduces TOR activity. 30 It is currently thought that the pseudocyst stage is irreversible and represents a defense form. Hence, a better understanding of the regulation of pseudocyst formation may provide additional information for the development of new therapeutics against trichomoniasis.
The serine/threonine protein phosphatase 2A (PP2A) (TVAG_008140) family is a large family of heterotrimeric enzymes that are highly conserved in all eukaryotes. Studies have demonstrated that PP2A activity is crucial for cell cycle regulation, cell survival, embryonic development and stress responses. 31, 32 More recently, attention has focused on the involvement of PP2A in tumorigenesis through regulation of cell transformation, which requires remarkable changes in cytoskeleton remodeling. Several cell types, such as neutrophils, hepatocytes, endothelial and epithelial cells, treated with PP2A inhibitors exhibit Factin disorganization, cell rounding and loss of cell polarity, suggesting that PP2A has a role in cytoskeleton organization. 33 In addition, other findings in plants indicate that okadaic acid, a PP2A inhibitor, enhances the cold response in wheat, tomato and Brassica napus leaves, suggesting that PP2As act as native regulators of low-temperature responses. 34 Given the importance of PP2A in regulation of the cytoskeleton and cold stress responses in other organisms, it would be worth studying the role of PP2A in the response to low temperature and in pseudocyst formation by T. vaginalis.
There have been many attempts to elucidate the roles of adhesion-related proteins in the pathogenesis of T. vaginalis; however, how the regulation of these proteins is not well understood. Calreticulin (CRT; TVAG_120870) is the only amoeboid-specific phosphorylated protein identified. It is a calcium (Ca 2þ )-binding protein with multiple functions and is predominantly located in the endoplasmic reticulum (ER). CRT is highly conserved in a diverse range of species. 35 In protists, the physiological and pathological significance of CRT remains to be defined. Entamoeba histolytica CRT (EhCRT) is remarkably immunogenic in patients with invasive amoebiasis. 36 In addition, EhCRT may play an important role in adapting to a new environment during the early stages of infection. In Trypanosoma cruzi, CRT translocates from the ER to the area of flagellum emergence and allows the parasite to recruit the complement component C1, which inhibits the classical pathway of human complement activation. 37 It has been proved that T. cruzi CRT is a novel virulence factor that promotes infectivity. 38 It has also been shown that CRT may regulate cellular adhesion and the expression of several adhesionrelated proteins, such as vinculin and N-cadherin. 39 Another study revealed that CRT is regulated by protein kinase C (PKC). 40 One of the post-translational modifications induced by PKC activation is tyrosine phosphorylation in CRT. Since CRT is involved in cellular adhesion and even in virulence of some protists, characterization of CRT in T. vaginalis may shed light on the regulation of adherence and further our understanding of the pathogenesis of T. vaginalis. The stage-specific phosphoproteins unique to T. vaginalis may play a role in the signaling involved in morphological transformation of the parasite.
The distribution of phosphoproteins identified in the three stages implies that different signal transduction cascades are activated. GO analysis of 41 annotatable proteins revealed that most proteins are located in the cell and have a binding function. The phosphopeptides detected in different stages revealed possible roles in the regulation of phosphorylation-based signaling pathways. The phosphoproteomics data sets generated in the present study will serve as a foundation for further characterization of the functions of these phosphoproteins. This could ultimately help in the identification of potential drug targets for the treatment of T. vaginalis infection.
